This review on the association between sickle cell disease (SCD) and asthma focusses on: 1) Our current understanding of the epidemiology of asthma, wheezing, airway obstruction, and airway responsiveness among patients with SCD; 2) The evidence supporting associations with SCD morbidity; 3) Our understanding of the pathophysiology of airway inflammation in SCD; 4) Current approaches to diagnosis and management of asthma in SCD; and 5) Future directions.
Recent Posts
- Quick Take: Depemokimab in Severe Asthma
- Analysis of the correlations and inconsistencies between spirometry and impulse oscillometry in the diagnosis of small-airway dysfunction
- Promoting Prevention and Targeting Remission of Asthma A EUFOREA Consensus Statement on Raising the Bar in Asthma Care
- Cost-related non-adherence to medications among adults with asthma in the USA, 2011–2022
- Allergen Immunotherapy: Optimal Duration for Respiratory Allergy